Psychoactive Substance Use by Adults With Schizophrenia Before and During Cannabis Withdrawal.
Clinical Research Program, Sheppard Pratt Health System, Baltimore, Maryland, and Department of Psychiatry and Behavioral Sciences, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Maju Mathew
MM
Koola
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Deanna L
DL
Kelly
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Robert P
RP
McMahon
Veterans Affairs Connecticut Healthcare System, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Douglas L
DL
Boggs
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Fang
F
Liu
dgorelick@mprc.umaryland.edu.|Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
David A
DA
Gorelick
D000328:Adult; D006801:Humans; D002189:Marijuana Abuse / Q000150:complications / Q000453:epidemiology*; D008875:Middle Aged; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012559:Schizophrenia / Q000150:complications / Q000453:epidemiology*; D012565:Schizophrenic Psychology; D013375:Substance Withdrawal Syndrome / Q000150:complications / Q000453:epidemiology*; D055815:Young Adult
D011619:Psychotropic Drugs